One Step to Defeat the Acute Myeloid Leukemia (AML) by Ultrasensitive Detection of Single Cancer Stem Cell

One Step to Defeat the Acute Myeloid Leukemia (AML) by Ultrasensitive Detection of Single Cancer Stem Cell


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: بلال خلیل زاده , مهدی مهدی پور , محمدرضا رشیدی شاهگلی

عنوان کنگره / همایش: سومین جشنواره ملی و کنگره بین المللی علوم و فناوری سلول های بنیادی و پزشکی بازساختی , Iran (Islamic Republic) , تهران , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله بلال خلیل زاده
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز سلولهای بنیادی
کد مقاله 65508
عنوان فارسی مقاله One Step to Defeat the Acute Myeloid Leukemia (AML) by Ultrasensitive Detection of Single Cancer Stem Cell
عنوان لاتین مقاله One Step to Defeat the Acute Myeloid Leukemia (AML) by Ultrasensitive Detection of Single Cancer Stem Cell
نوع ارائه سخنرانی
عنوان کنگره / همایش سومین جشنواره ملی و کنگره بین المللی علوم و فناوری سلول های بنیادی و پزشکی بازساختی
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش Iran (Islamic Republic)
شهر محل برگزاری کنگره/ همایش تهران
سال انتشار/ ارائه شمسی 1397
سال انتشار/ارائه میلادی 2018
تاریخ شمسی شروع و خاتمه کنگره/همایش 1397/09/07 الی 1397/09/10
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
بلال خلیل زادهدوم
مهدی مهدی پورسوم
محمدرضا رشیدی شاهگلیهفتم

اطلاعات تفضیلی
hide/show

عنوان متن
کلمات کلیدیStem cell biosensing; Electrochemical; Cytosensor; Single cell detection; CD123; AML
خلاصه مقالهAbstract: Background and Aim: One of the most common types of blood cancer is acute myeloid leukemia (AML), which highly affects the blood cells, in the context of bone marrow and other tissues. The leukemia stem cells (LSCs) have a very important role in the refractory and relapse of AML. So monitoring of LSCs is so critical during the diagnosis, and therapeutic period of AML suffering patients. Methods: In this regard, we developed an electrochemical-based cytosensor for detection and quantification of LSCs. For this aim, we designed an immunosensor for detection of cell surface marker of CD123, which were overexpressed in the surface of KG1a cell line as a model of LSCs. It is important to declare that, approximately more than 75% of the CD123 protein is accessible and located outside of LSCs membrane. Graphene quantum dots (GQDs) for their specific properties like high surface area, electrical conductivity, and optical properties were used as electrode platform. The glassy carbon electrode (GCE) was used as the working electrode and stepwise modified by GQDs, Au nanoparticles (AuNPs), streptavidin coated AuNPs (star-shaped), biotinylated CD123 antibody and target cells. The biotinylated antibody was used as a cell capturing element. Results: All of the electrode preparation steps were confirmed by cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) techniques. After passing the optimization of all experimental parameters, the detection limit (DL) and linear dynamic range (LDR) of the designed cytosensor were obtained as 1 cell/mL and 1 to 50 cells/mL, respectively. Conclusion: The constructed nanomaterial-based cytosensor has top features like ultra-sensitivity, easy fabrication process and more precise results, which make it as a useful analytical device for detection and quantification of LSCs in clinical laboratories.

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
68-69.pdf1397/10/1069839دانلود
certificate 1.pdf1397/10/10388899دانلود
certificate 2.pdf1397/10/10338989دانلود